Markets finish week down after bouncing on Bannon's exit >>> READ MORE


Recent Articles

Amgen, Inc. (AMGN) Stock Is a Trade for Ailing Portfolios

Investors fear Amgen (AMGN) is a falling knife after dropping on earnings. Use that fear to sell puts for income in AMGN stock. More 

The Bulls’ Banner Waves in the SPDR S&P Biotech (ETF) (XBI)

The SPDR S&P Biotech ETF is forming a bull flag. Here's how to play biotech stocks for profit in XBI. More 

Dipping Celgene Corporation (CELG) Stock Is Begging to Be Bought

Biotech stocks, including Celgene, are pulling back. CELG stock is one of the best dip-buying opportunities of the bunch. More 

Play the iShares Nasdaq Biotechnology Index (ETF)’s (IBB) Popularity for Free

ETFs should not move 11% in four days. The IBB just did that, so I will short it with no money out of pocket. Bet against the herd mentality. More 

Is the SPDR S&P Biotech (ETF) (XBI) Done Running?

Biotech stocks are booming, but resistance looms close. Time to take profits on the SPDR S&P Biotech (ETF) XBI calls, but also consider reloading. More 

Trade of the Day: SPDR S&P Biotech (ETF) (XBI)

XBI hit a new 52-week high of $76.60 on Tuesday before easing back slightly to about $75. And I'm opting to employ one of my preferred bullish strategies here. More 

The SPDR S&P Biotech (ETF) (XBI) Is on Breakout Watch

Biotech stocks are quietly climbing higher. Here's how to trade the SPDR S&P Biotech (ETF) (XBI) before its seemingly imminent pop. More